This week in Maryland the first human trial with the Ebola vaccine is expected to take place. The Ebola virus is currently killing people in West Africa and at an alarming rate. There has been more than 3,000 confirmed cases and it appears that the virus is not showing signs of slowing down. The World Health Organization estimates that the Ebola epidemic could surpass 20,000 cases in West Africa.
Recently, two American workers contracted Ebola and received an experimental drug which cured them of the virus. Currently there is no vaccine for the virus. The first part of the trial is multi-stage and will include 20 healthy adults between the ages of 18 and 50. The testing will take place in Bethesda at the NIH. The same vaccine will be tested in Mali, Gambia and the United Kingdom. The NIH believes they are ready to test on humans after several years of working on vaccines and “co-developed” with the Glaxo Smith Kline. The results of the initial trial will be available at the end of the year.